119th Congress · introduced in the Senate · Apr 9, 2025
National Biotechnology Initiative Act of 2025
Official title from Congress.gov
Latest action (Mar 19, 2026): Committee on Health, Education, Labor, and Pensions. Hearings held.
View on Congress.govPolicy area: Science, Technology, Communications
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Committee on Health, Education, Labor, and Pensions. Hearings held.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Actions from Congress.gov, newest first.
Administrative law and regulatory procedures · Advanced technology and technological innovations · Advisory bodies · Biological and life sciences · Congressional oversight · Data collection, sharing, protection · Employment and training programs · Executive agency funding and structure · Executive Office of the President · Government information and archives · Internet, web applications, social media · Research administration and funding · Research and development · Technology transfer and commercialization
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 23, 2026.
26 citations; showing the 25 most recently posted.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$7,040,000
Spent on own lobbying
…652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
GSK (FKA GLAXOSMITHKLINE INC.) · lobbying firm or registrant: GSK (FKA GLAXOSMITHKLINE INC.)
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$1,530,000
Spent on own lobbying
…652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
KERRY INC. AND AFFILIATES OWNED BY KERRY HOLDING CO INCLUDING NIACET CORPORATION · lobbying firm or registrant: KERRY INC. AND AFFILIATES OWNED BY KERRY HOLDING CO INCLUDING NIACET CORPORATION
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Science/Technology
$100,000
Spent on own lobbying
…nology initiatives, including recommendations of the National Security Commission on Emerging Biotechnology, the National Biotechnology Initiative Act of 2025 (S. 1387), and potential biotechnology provisions under consideration in the National Defense Authorization Act. Also provided briefings and demonstrations regarding ad…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
WITH HONOR ACTION, INC. · lobbying firm or registrant: WITH HONOR ACTION, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Science/Technology
$140,000
Spent on own lobbying
H.R.2756/S.1387, National Biotechnology Initiative Act of 2025 H.R.1604/S.754, Farm and Food Cybersecurity Act H.R.2109/S.1018, The Cybersecurity for Rural Water Systems Act o…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY FOR MICROBIOLOGY · lobbying firm or registrant: AMERICAN SOCIETY FOR MICROBIOLOGY
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 19, 2026 · issue area: Science/Technology
$50,000
Spent on own lobbying
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676); Homestake AI Act of 2026 (S. 4991).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ALLIANCE FOR BIOMANUFACTURING · lobbying firm or registrant: CASSIDY & ASSOCIATES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 7, 2026 · issue area: Science/Technology
$60,000
Paid to lobbying firm
biomanufacturing and technology S.4781 - Make More in America Act of 2026 S.1387 - National Biotechnology Initiative Act of 2025 H.R.2756 - National Biotechnology Initiative Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ALLIANCE FOR BIOMANUFACTURING · lobbying firm or registrant: CASSIDY & ASSOCIATES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 7, 2026 · issue area: Manufacturing
$60,000
Paid to lobbying firm
biomanufacturing and technology S.4781 - Make More in America Act of 2026 S.1387 - National Biotechnology Initiative Act of 2025 H.R.2756 - National Biotechnology Initiative Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVOZYMES NORTH AMERICA, INC. · lobbying firm or registrant: NOVOZYMES NORTH AMERICA, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Agriculture
$140,000
Spent on own lobbying
…tion Program, biological products in agriculture, biotechnology and biological products, including the National Biotechnology Initiative Act of 2025 (H.R. 2756/S. 1387), and issues related to dietary supplements including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to nutrition, FDA regulation…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ARCHER DANIELS MIDLAND COMPANY · lobbying firm or registrant: ARCHER DANIELS MIDLAND COMPANY
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Manufacturing
$1,500,000
Spent on own lobbying
…Act of 2025; provisions related to biomanufacturing H.R. 8800: National Defense Authorization Act for Fiscal Year 2027; provisions related to biomanufacturing S. 1387: National Biotechnology Initiative Act of 2025; provisions related to biomanufacturing S. ____: National Defense Authorization Act, 2027; provisions related to…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · lobbying firm or registrant: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Health Issues
$7,360,000
Spent on own lobbying
…652: Protecting Patients from Deceptive Drug Ads Act S. 832: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 S. 864: HELP Copays Act S. 1387: National Biotechnology Initiative Act of 2025 S. 1414: Expedited Access to Biosimilars Act S. 1954: Biosimilar Red Tape Elimination Act S. 2296: BIOSECURE Act…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
WITH HONOR ACTION, INC. · lobbying firm or registrant: WITH HONOR ACTION, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 20, 2026 · issue area: Science/Technology
$140,000
Spent on own lobbying
H.R.2756/S.1387, National Biotechnology Initiative Act of 2025 H.R.1604/S.754, Farm and Food Cybersecurity Act H.R.2109/S.1018, The Cybersecurity for Rural Water Systems Act o…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY FOR MICROBIOLOGY · lobbying firm or registrant: AMERICAN SOCIETY FOR MICROBIOLOGY
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 17, 2026 · issue area: Science/Technology
$50,000
Spent on own lobbying
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676);
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ALLIANCE FOR BIOMANUFACTURING · lobbying firm or registrant: CASSIDY & ASSOCIATES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 15, 2026 · issue area: Science/Technology
$60,000
Paid to lobbying firm
biomanufacturing and technology S.4781 - Make More in America Act of 2026 S.1387 - National Biotechnology Initiative Act of 2025 H.R.2756 - National Biotechnology Initiative Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN ALLIANCE FOR BIOMANUFACTURING · lobbying firm or registrant: CASSIDY & ASSOCIATES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 15, 2026 · issue area: Manufacturing
$60,000
Paid to lobbying firm
biomanufacturing and technology S.4781 - Make More in America Act of 2026 S.1387 - National Biotechnology Initiative Act of 2025 H.R.2756 - National Biotechnology Initiative Act of 2025
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ARCHER DANIELS MIDLAND COMPANY · lobbying firm or registrant: ARCHER DANIELS MIDLAND COMPANY
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 21, 2026 · issue area: Manufacturing
$2,050,000
Spent on own lobbying
H.R. 2756: National Biotechnology Initiative Act of 2025; provisions related to biomanufacturing S. 1387: National Biotechnology Initiative Act of 2025; provisions related to biomanufacturing P.L. 119-60 (S. 1071): National Defense Authorization Act for Fiscal Yea…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
WITH HONOR ACTION, INC. · lobbying firm or registrant: WITH HONOR ACTION, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Science/Technology
$50,000
Spent on own lobbying
H.R.2756/S.1387, National Biotechnology Initiative Act of 2025 S.3597, National Quantum Initiative Reauthorization Act of 2026 Issues related to biotechnology research, develo…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY FOR MICROBIOLOGY · lobbying firm or registrant: AMERICAN SOCIETY FOR MICROBIOLOGY
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Science/Technology
$50,000
Spent on own lobbying
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676);
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVOZYMES NORTH AMERICA, INC. · lobbying firm or registrant: NOVOZYMES NORTH AMERICA, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Agriculture
$220,000
Spent on own lobbying
…tification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. H.R. 7366 - Dietary Supplement Regulatory Uniformity Act - Issues related to dietary supplements.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ARCHER DANIELS MIDLAND COMPANY · lobbying firm or registrant: ARCHER DANIELS MIDLAND COMPANY
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 21, 2026 · issue area: Manufacturing
$1,320,000
Spent on own lobbying
H.R. 2756: National Biotechnology Initiative Act of 2025; provisions related to biomanufacturing S. 1387: National Biotechnology Initiative Act of 2025; provisions related to biomanufacturing P.L. 119-60 (S. 1071): National Defense Authorization Act for Fiscal Yea…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
WITH HONOR ACTION, INC. · lobbying firm or registrant: WITH HONOR ACTION, INC.
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Science/Technology
$60,000
Spent on own lobbying
H.R.1604/S.754, Farm and Food Cybersecurity Act H.R.2109/S.1018, The Cybersecurity for Rural Water Systems Act of 2025 H.R.2756/S.1387, National Biotechnology Initiative Act of 2025 Issues related to biotechnology research, development, and manufacturing
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NOVOZYMES NORTH AMERICA, INC. · lobbying firm or registrant: NOVOZYMES NORTH AMERICA, INC.
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 20, 2026 · issue area: Agriculture
$150,000
Spent on own lobbying
…tification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. Issues related to dietary supplements - no specific legislation.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY FOR MICROBIOLOGY · lobbying firm or registrant: AMERICAN SOCIETY FOR MICROBIOLOGY
2025 Q4 report (Oct 1, 2025 – Dec 31, 2025) · posted Jan 14, 2026 · issue area: Science/Technology
$50,000
Spent on own lobbying
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
WITH HONOR ACTION, INC. · lobbying firm or registrant: WITH HONOR ACTION, INC.
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 20, 2025 · issue area: Science/Technology
$70,000
Spent on own lobbying
H.R.1604/S.754, Farm and Food Cybersecurity Act H.R.2109/S.1018, The Cybersecurity for Rural Water Systems Act of 2025 H.R.2756/S.1387, National Biotechnology Initiative Act of 2025 Issues related to biotechnology research, development, and manufacturing (David Sean McClintock only lobbied the…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
AMERICAN SOCIETY FOR MICROBIOLOGY · lobbying firm or registrant: AMERICAN SOCIETY FOR MICROBIOLOGY
2025 Q3 report (Jul 1, 2025 – Sep 30, 2025) · posted Oct 17, 2025 · issue area: Science/Technology
$50,000
Spent on own lobbying
Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
WITH HONOR ACTION, INC. · lobbying firm or registrant: WITH HONOR ACTION, INC.
2025 Q2 report (Apr 1, 2025 – Jun 30, 2025) · posted Jul 21, 2025 · issue area: Science/Technology
$80,000
Spent on own lobbying
H.R.1604/S.754, Farm and Food Cybersecurity Act H.R.2109/S.1018, The Cybersecurity for Rural Water Systems Act of 2025 H.R.2756/S.1387, National Biotechnology Initiative Act of 2025 Issues related to biotechnology research, development, and manufacturing (David Sean McClintock only lobbied the…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing